News in 2019
Authors:
Lukáš M.
Authors‘ workplace:
Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F. a. s., Praha
Published in:
Gastroent Hepatol 2019; 73(1): 5
Category:
Editorial
Labels
Paediatric gastroenterology Gastroenterology and hepatology SurgeryArticle was published in
Gastroenterology and Hepatology
2019 Issue 1
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Metamizole vs. Tramadol in Postoperative Analgesia
- The Importance of Hydration in Wound Healing
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
-
All articles in this issue
- News in 2019
- Biologics for inflammatory bowel disease – forth time
- Inflammatory bowel disease and medical assessment service
- Treatment of a pregnant Crohn’s disease patient with ustekinumab: a case report
- Surprising etiology of terminal common bile duct stricture
- Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal reflux
- Does abdominal compression improve the success rate of and tolerance to colonoscopy?
- Toxic and drug damage of the liver and kidneys
- The selection from international journals
- Clensia® – the first combined cleansing agent with simeticone
- Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice
- Early vedolizumab trough levels are not associated with short-term response in patients with inflammatory bowel disease
- Ileocaecal Crohn’s disease and familial adenomatous polyposis in one patient – a case report
- First European Conference of Young Gastroenterologists – ECYG
- Gastroenterology and Hepatology
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Clensia® – the first combined cleansing agent with simeticone
- Toxic and drug damage of the liver and kidneys
- Surprising etiology of terminal common bile duct stricture
- Therapeutic trial of proton pump inhibitors for management of patients with laryngopharyngeal reflux